Replies to post #49044 on Amarin Corp Plc (AMRN)

[ggwpq]

Amarin is not an earning story like Apple. As long as script growth is in an uptrend and not falling behind other lipid lowering drugs, shareholders should take a longer term view. Most important for Amarin is patents, R-I success and NCE in that order.